http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107677825-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57411 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-531 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-531 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
filingDate | 2017-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2019-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2019-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-107677825-B |
titleOfInvention | A kind of tumor diagnosis composition for diagnosis of cervical cancer and the purposes for being used to prepare diagnostic kit |
abstract | The invention discloses a kind of tumor diagnosis compositions for diagnosis of cervical cancer and the purposes for being used to prepare diagnostic kit.When serum hemolysis phosphatidyl choline (18:2), phosphatidylinositols (20:4/0:0) or N- phenylpropyl alcohol acyl-L-Glutamine diagnosis differentiation cervical cancer patient and healthy volunteer is used alone, area (AUC) is below 0.7 under ROC curve;AUC can be improved to 0.945 when triple combination distinguishes cervical cancer patient and healthy volunteer for diagnosing.One skilled in the art will appreciate that area is between 1.0 and 0.5 under ROC curve, in the case where AUC > 0.5, AUC illustrates that diagnosis effect is better closer to 1.AUC has lower accuracy in 0.5-0.7, and AUC has certain accuracy in 0.7-0.9, and AUC has high accuracy at 0.9 or more.Therefore, serum hemolysis phosphatidyl choline (18:2), phosphatidylinositols (20:4/0:0) and N- phenylpropyl alcohol acyl-L-Glutamine can combine the diagnostic kit for being used to prepare diagnosing cervical. |
priorityDate | 2017-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 33.